Primex Pharmaceuticals is an innovative and fast-growing company spearheading a new pharmaceutical business model, in operation since early 2008. It has a global reach through regional marketing and distribution.
Primex supplies high-quality medicines to healthcare institutions and professionals around the world, from the EU to Asia, and from Latin America to the Middle East. Primex products are available in a total of 39 countries world-wide, while its distribution reaches a population of nearly one billion people.
Primex is specialized in anesthesia, cardiology, oncology and intensive care, and constantly expanding. Primex markets world class brands, such as Dobuject and Recofol, all over the world. Both are the most advanced versions in their categories.